arrow
T

Terry M. Therneau

Mayo Clinic
H指数:133
被引数:8.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lifetime and 10-year absolute risk of cognitive impairment in relation to amyloid PET severity: a retrospective, longitudinal cohort study

与淀粉样蛋白PET严重程度相关的认知障碍的终身及10年绝对风险:一项回顾性、纵向队列研究

2025-11-120
PRE
Association between antemortem plasma and structural MRI biomarkers and postmortem tau pathology in the Mayo Clinic Study of Aging

梅奥诊所老龄化研究中,抗-mortem血浆和结构MRI生物标志物与死后tau病理学之间的关系

2025-10-150
OAAI
Staging Alzheimer’s disease through amyloid and tau PET

通过淀粉样蛋白和tau PET对阿尔茨海默病进行分期

Brain
IF11.7
2025-09-190
PRE
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals

血浆阿尔茨海默病生物标志物与认知功能完好个体认知下降的关联

2025-08-290
OAAI
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals

比较血浆生物标志物和淀粉样蛋白PET预测认知未受损个体的记忆力下降

2024-01-248
OA
Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET

模拟血浆p-tau与淀粉样蛋白 β 和tau PET的时间演变

2023-11-148
OA
Predicting amyloid PET and tau PET stages with plasma biomarkers

用血浆生物标志物预测淀粉样蛋白PET和tau PET分期

BRAIN
IF11.7
2023-02-1546
OAAI
CSF phosphorylated tau as an indicator of subsequent tau accumulation

CSF磷酸化tau作为随后tau积累的指标

2022-09-015
OAAI
Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
2022-02-0222
OAAI